Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne (PAS-CD) (PAS-CD)

Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne.

Sexual addiction, also known as hypersexuality or compulsive sexuality, is a human sexual behavior that results in a continuous and persistent search for sexual pleasure. Replacing the former terms satyriasis and nymphomania, the World Health Organization (WHO) ICD-11 has referred to this disorder as "compulsive sexual behavior disorders".

From multiple causes (iatrogeny, neurological causes, psychiatric causes, psychopathological hypotheses), but still only partially known, the inclusion of this disorder among impulsivity-related disorders, obsessive-compulsive disorders or addiction-related disorders is still debated in the scientific literature. Thus, in the absence of sufficient robust scientific data, DSM-5 refused to include this disorder in its classification.

However, the consequences of this disorder on the psychosocial functioning of individuals are not negligible, which can go as far as the precipitation of a transition to an heteroaggressive act which can thus lead to incarceration.

The prevalence of this disorder in the general population is estimated between 2 and 6% based on current literature data. This rate appears to be higher among men and more specifically among sex offenders.

However, some authors have noted that the difficulty in determining a clear prevalence of sexual addiction may be related to the still poorly defined diagnostic criteria for this disorder as well as the choice of measurement tools.

In the inmate population, to our knowledge, there are no French prevalence studies of this disorder. In addition, no studies have been conducted to compare the prevalence of sexual addiction among sex offenders (SASO) with that among non-sex offenders (SANSO).

We hope that better screening for addiction would enable better management of patients with this disorder, promoting their psychosocial rehabilitation and well-being, so as to prevent the recurrence of a transition to sexual arousal.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study is intended to assess the prevalence of sexual addiction among a population of detainees at the Muret detention center in Haute-Garonne.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Toulouse, France, 31000
        • Julien DA COSTA
        • Contact:
        • Principal Investigator:
          • Julien JD Da Costa, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male subjects
  • Detainees at Muret Detention Center
  • Aged between 18 and 65 at the time of the search
  • And having agreed to participate in the research.

Exclusion Criteria:

  • Person under legal protection, guardianship or curatorship ;
  • Insufficient command of the French language
  • Existence of cognitive disorders preventing a good understanding of the information relating to the study or the various questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Interviews
semi-directive interview
semi-structured interview conducted by a psychiatrist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The main objective is to determine the prevalence of sexual addiction among a population of men incarcerated at the Muret detention center in Haute-Garonne.
Time Frame: Day 1
The primary endpoint is the presence of a patient's sexual addiction defined by a score greater than 13 on the Carnes screening test.
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determine the prevalence of sexual addiction in a population of sexual offenders
Time Frame: Day 1
The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.
Day 1
Determine the prevalence of sexual addiction in a population of non-sexual offenders
Time Frame: Day 1
The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.
Day 1
Compare the prevalence of sexual addiction in these two populations
Time Frame: Day 1
The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.
Day 1
Determine any addictive and psychiatric co-morbidities associated with each population
Time Frame: Day 1
The presence of psychiatric disorders is defined using the Mini International Neuropsychiatric Interview (MINI) scale.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2022

Primary Completion (Anticipated)

August 1, 2022

Study Completion (Anticipated)

August 1, 2024

Study Registration Dates

First Submitted

July 29, 2022

First Submitted That Met QC Criteria

July 29, 2022

First Posted (Actual)

August 2, 2022

Study Record Updates

Last Update Posted (Actual)

August 2, 2022

Last Update Submitted That Met QC Criteria

July 29, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-A00342-41

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Addiction

Clinical Trials on semi-structured Interviews

3
Subscribe